These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 14592689)
1. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat. Redwine KE; Trujillo KA Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689 [TBL] [Abstract][Full Text] [Related]
2. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. Fischer BD; Carrigan KA; Dykstra LA J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820 [TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162 [TBL] [Abstract][Full Text] [Related]
4. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809 [TBL] [Abstract][Full Text] [Related]
5. NMDA antagonist modulation of morphine antinociception in female vs. male rats. Craft RM; Lee DA Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534 [TBL] [Abstract][Full Text] [Related]
6. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Baker AK; Hoffmann VL; Meert TF Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154 [TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. Allen RM; Dykstra LA J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554 [TBL] [Abstract][Full Text] [Related]
8. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors. McNally GP; Westbrook RF Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude. Allen RM; Dykstra LA J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436 [TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats. Holtman JR; Jing X; Wala EP Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680 [TBL] [Abstract][Full Text] [Related]
11. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731 [TBL] [Abstract][Full Text] [Related]
12. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine. Nishiyama T; Yaksh TL; Weber E Anesthesiology; 1998 Sep; 89(3):715-22. PubMed ID: 9743410 [TBL] [Abstract][Full Text] [Related]
13. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Allen RM; Dykstra LA Psychopharmacology (Berl); 1999 Feb; 142(2):209-14. PubMed ID: 10102774 [TBL] [Abstract][Full Text] [Related]
14. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688 [TBL] [Abstract][Full Text] [Related]
15. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Bespalov A; Kudryashova M; Zvartau E Eur J Pharmacol; 1998 Jun; 351(3):299-305. PubMed ID: 9721021 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Kozela E; Pilc A; Popik P Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203 [TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan potentiates morphine antinociception at the spinal level in rats. Chow LH; Huang EY; Ho ST; Lee TY; Tao PL Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats. Bhargava HN; Thorat SN Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999 [TBL] [Abstract][Full Text] [Related]
19. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Popik P; Kozela E; Danysz W Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858 [TBL] [Abstract][Full Text] [Related]
20. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice. Malec D; Mandryk M; Fidecka S Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]